Daniel Marini
Geschäftsführer bei ROBEX RESOURCES INC.
Vermögen: - $ am 30.04.2024
Aktive Positionen von Daniel Marini
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ROBEX RESOURCES INC. | Geschäftsführer | 21.09.2023 | - |
| Corporate Officer/Principal | 01.06.2023 | 21.09.2023 | |
EryPharm SAS
 EryPharm SAS BiotechnologyHealth Technology Part of Safi Biotherapeutics, Inc., EryPharm SAS is a biotech startup based in Paris, France. EryPharm is focused on the development of cultured red blood cells (CRBCs) technology, which was pioneered by the team in 2002. The French company aims to confirm the product's non-toxicity through clinical trials in 2022, followed by trials in 2023 to confirm the benefits of CRBCs. The go-to-market authorization is expected in 2028 at the latest. EryPharm SAS was founded in 2016 by Prof. Luc Douay's team, a spin-off from Sorbonne University. The CEO is Daniel Marini. EryPharm was acquired by Safi Biotherapeutics, Inc. on January 05, 2024. | Vorstandsvorsitzender | - | - |
Karriereverlauf von Daniel Marini
Ehemalige bekannte Positionen von Daniel Marini
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Assala Energy UK Ltd.
 Assala Energy UK Ltd. MiscellaneousMiscellaneous Assala Energy UK Ltd. operates as a holding company that engages in oil exploration and production. It operates five fields and has four interests in four non-operated fields. The company is headquartered in London, the United Kingdom. | Direktor/Vorstandsmitglied | - | - |
| Corporate Officer/Principal | - | - | |
| Grande Côte Operations SA | Vorstandsvorsitzender | - | - |
Statistik
International
| Australien | 2 |
| Kanada | 2 |
| Vereinigtes Königreich | 2 |
Operativ
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
Sektoral
| Non-Energy Minerals | 2 |
| Miscellaneous | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ROBEX RESOURCES INC. | Non-Energy Minerals |
| Private Unternehmen | 3 |
|---|---|
| Grande Côte Operations SA | |
Assala Energy UK Ltd.
Assala Energy UK Ltd. MiscellaneousMiscellaneous Assala Energy UK Ltd. operates as a holding company that engages in oil exploration and production. It operates five fields and has four interests in four non-operated fields. The company is headquartered in London, the United Kingdom. | Miscellaneous |
EryPharm SAS
EryPharm SAS BiotechnologyHealth Technology Part of Safi Biotherapeutics, Inc., EryPharm SAS is a biotech startup based in Paris, France. EryPharm is focused on the development of cultured red blood cells (CRBCs) technology, which was pioneered by the team in 2002. The French company aims to confirm the product's non-toxicity through clinical trials in 2022, followed by trials in 2023 to confirm the benefits of CRBCs. The go-to-market authorization is expected in 2028 at the latest. EryPharm SAS was founded in 2016 by Prof. Luc Douay's team, a spin-off from Sorbonne University. The CEO is Daniel Marini. EryPharm was acquired by Safi Biotherapeutics, Inc. on January 05, 2024. | Health Technology |
- Börse
- Insiders
- Daniel Marini
- Erfahrung
